XW-032
Product Specifications
Target
IDO|||Indoleamine 2,3-Dioxygenase (IDO)
Related Pathways
Metabolism
Bioactivity
XW-032 is an apo-IDO1 inhibitor with an IC50 of 21 nM. In the CT26 syngeneic mouse model, XW-032 demonstrates significant in vivo antitumor efficacy with a TGI of 63%, showing potential for cancer research applications.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
042291-ML490 100 µL
SRC, NT (SRC, SRC1, Proto-oncogene tyrosine-protein kinase Src, Proto-oncogene c-Src, pp60c-src) (MaxLight 490) discontinued
Ask
View Details 